Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 75, Issue 3, 2010, Pages 375-380

  Ahmed, Abid Riaz ^a   Dashevsky, Andrei ^a   Bodmeier, Roland ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Controlled drug release; In situ cubic phase; Monoglyceride; Oligonucleotide; Sterilization

Indexed keywords

GLYCEROL MONOLINOLEATE; GLYCEROL OLEATE; GMORPHIC 80; MONOACYLGLYCEROL; OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID DERIVATIVE; RYLO MG 13; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CULTURE; COLIFORM BACTERIUM; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; INSTRUMENT STERILIZATION; MACROMOLECULE; MEASUREMENT; PHASE FORMING FORMULATION; PSEUDOMONAS AERUGINOSA; VISCOSITY;

DRUG DELIVERY SYSTEMS; MONOGLYCERIDES; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 77954538778     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.04.004     Document Type: Article

References (21)

1. Schwendeman S.T., Cardamone M., Brandon M.R., Klibanov A., Langer R. Stability of proteins and their delivery from biodegradable polymer microspheres. Microparticulate Systems for the Delivery of Proteins and Vaccines 1996, 1-50. Marcel Dekker, New York. S. Cohen, H. Bernstein (Eds.).
2. Ahmed A.R., Bodmeier R. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading. Eur. J. Pharm. Biopharm. 2009, 71:264-270.
3. Mok H., Park T.G. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent. Eur. J Pharm. Biopharm. 2008, 70:137-144.
4. Ahmed A.R., Dashevsky A., Bodmeier R. Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems. Eur. J. Pharm. Biopharm. 2008, 70:765-769.
5. Fattal E., Bochot A. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Int. J. Pharm. 2008, 364:237-248.
6. Nafee N., Taetz S., Schneider M., Schaefer U.F., Lehr C. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomed. Nanotechnol. Biol. Med. 2007, 3:173-183.
7. Chiu S., Liu S., Perrotti D., Marcucci G., Lee R.J. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J. Control. Rel. 2006, 112:199-207.
8. Norling T., Lading P., Engstrom S., Larsson K., Krog N., Nissen S.S. Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontol disease. J. Clin. Periodontol. 1992, 19:687-692.
9. Appel L., Engel K., Jensen J., Rejewski L., Zenter G. An in-vitro model to mimic in-vivo subcutaneous monoolein degradation. Pharm. Res. 1994, 11:217-225.
10. C. Chang, Application of monoglyceride-based material as sustained-release drug carriers, Ph.D. Thesis, College of Pharmacy, The University of Taxes at Austin, Austin, TX 78712, USA, 1995.
11. Engström S., Lindahl L., Wallin R., Engblom J. A study of polar lipid drug carrier systems undergoing a thermo-reversible lamellar-to-cubic phase transition. Int. J. Pharm. 1992, 86:137-145.
12. Chang C., Bodmeier R. Binding of drugs to monoglyceride based drug delivery systems. Int. J. Pharm. 1997, 147:135-142.
13. Chang C., Bodmeier R. Swelling of and drug release from monoglyceride based drug delivery systems. J. Pharm. Sci. 1997, 86:747-752.
14. Chang C., Bodmeier R. Low viscosity monoglyceride-based drug delivery systems transforming into a highly viscous cubic phase. Int. J. Pharm. 1998, 173:51-60.
15. Lee J., Kellaway I.W. Buccal permeation of [d-Ala2, d-Leu5]enkephalin from liquid crystalline phases of glyceryl monooleate. Int. J. Pharm. 2000, 195:35-38.
16. Lee J., Kellaway I.W. In vitro peptide release from liquid crystalline buccal delivery systems. Int. J. Pharm. 2000, 195:29-33.
17. Shah J.C., Sadhale Y., Chilukuri D.M. Cubic phase gels as drug delivery systems. Adv. Drug Deliv. Rev. 2001, 47:229-250.
18. Sadhale Y., Shah J.C. Biological activity of insulin in GMO gels and the effect of agitation. Int. J. Pharm. 1999, 191:65-74.
19. Sadhale Y., Shah J.C. Stabilisation of insulin against agitation-induced aggregation by the GMO cubic phase gel. Int. J. Pharm. 1999, 191:51-64.
20. Nielsen L.S., Schubert L., Hansen J. Bioadhesive drug delivery systems 1. Characterisation of mucoadhesive properties of systems based on glyceryl monooleate and glyceryl monoli-noleate. Eur. J. Pharm. Sci. 1998, 6:231-239.
21. H. Kranz, In situ forming biodegradable drug delivery systems, Ph.D. Thesis, College of Pharmacy, Freie Universität Berlin, Germany, 2000, pp. 84-85.